Protection through 2039, ensuring long-term commercial exclusivity. NEW YORK, June 12, 2025 — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies, today announced that they have obtained Japan Country Patent No. 7677628 […]
Premier Research to support submission of an Expanded Access Program (EAP) application. This move positions Hoth to offer compassionate access to HT-001 for cancer patients suffering from painful and debilitating skin toxicities caused by epidermal […]
The proprietary Self-Emulsifying Drug Delivery System (SEDDS) formulation in form of orally dispersible films allows absorption of sublingually administrated peptides such as GLP-1 (Semaglutide, Liraglutide etc.). The new formulation is expected to offer alternatives to both approved […]
Successful robotic navigation was achieved in every case and met the primary endpoint of the study LIBERTY® showed a 92% reduction in radiation exposure with no adverse events reported HINGHAM, Mass., April 09, 2025 — Microbot Medical […]
ABVC BioPharma (NASDAQ: ABVC) CEO Interview with Uttam Patil ABVC BioPharma (NASDAQ: ABVC) CEO Interview with Uttam Patil discussing the company’s drug development pipeline, and upcoming milestones.
Highlights: AI/ML’s subsidiary, Tech2heal, expands its global footprint with second clinical trial contract – conducted jointly by French and Italian University Hospitals. The clinical trial is funded by a European Commission fund. The study includes […]
Highlights: The clinical study, led by the University Hospital of Nice, France involves 30,000 patients. AI/ML Innovations’ subsidiary, Tech2Heal, has been chosen to provide the “technological backbone” for the study. Tech2heal has been awarded a […]
Vancouver, British Columbia–April 26, 2023 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory […]
Vancouver, British Columbia– – April 18, 2023- Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for […]
Vancouver, British Columbia– April 11, 2023 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for […]
Health Coach has functionality similar to ChatGPT, but is designed to monitor and manage the users health. Health Coach provides conversational personal health goal setting and care recommendations by directly accessing and utilizing a user’s […]
NEXT SUPER STOCK Nova Mentis Life Sciences (OTC: NMLSF) Psilocybin for Autism FXS – Patient Enrollment for Phase 2A Clinical Trials Update
Vancouver, British Columbia— April 5, 2023- Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory […]
Vancouver, British Columbia–March 29, 2023 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory […]
The Study, Led by the University Hospital of Nice, France Involves 30,000 Patients Tech2Heal’s Platform has been chosen as the technological backbone for the Study 3.4million Europeans live in assisted-care facilities, and 101million are 65 […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
